Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of sourcing active pharmaceutical ingredients (APIs) and intermediates also has become more challenging. Today, finding the right balance between supply chain security, API quality, and price is more difficult than ever – and the consequences of successful supplier selection can be monumental.
LGM can help ensure your supply chain is secure by providing:
Access to a portfolio of over 2,000 APIs
From every therapeutic category to support any stage of development, from early feasibility to commercial production.
Support programs as a primary or alternate source, from R&D through commercialization
Risk mitigation strategies for your supply chain by providing multiple sources from divergent geographical regions.
Robust network of 150+ reliable API manufacturers
With a tradition of regulatory excellence – holding approvals from leading health authorities (FDA, EDQM, TGA, UK-MHRA and others) – backed by accessible & comprehensive DMF / regulatory documentation.
To understand the unique needs of your project and the timeline for development or commercialization.
Global regulatory expertise
Ensuring a smooth journey from concept to regulatory approval in the USA, EU and other highly regulated markets.
Learn how LGM Pharma can help you mitigate risk while expediting timelines.
Read more about supply chain:
COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of many other, more localized supply issues in the last
When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains already were circulating. The issues at hand weren’t new, by any